Zacks Investment Research
14 Oct 2025, 18:16 UTC · 48w ago
Verdict
Headline takes no side. We score AMWL −0.80 across four claims — strongly bearish.
−0.80strongly bearish
More negative than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Hims & Hers raised its revenue guidance, projecting Q3 2025 revenues between $570 million and $590 million (up 42-47% year over year) and full-year 2025 revenues of $2.3 billion to $2.4 billion (up 56-63% from 2024).
So whatStrong double-digit top-line growth guidance significantly exceeding prior-year levels signals robust demand and is highly likely to positively influence the stock's valuation.
More positive than 96% of claims this week
Hims & Hers' gross margin contracted in Q2 2025 due to rising product costs.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 87% of claims this week
Hims & Hers' aggressive expansion strategy, including its recent ZAVA acquisition, is amplifying operational complexities and regulatory exposure.
More negative than 81% of claims this week
Hims & Hers launched a new category in men's health in September 2025.
More positive than 64% of claims this week
Which stocks this story touches
More negative than 87% of ticker scores this week
The company's shares lost 28.6% over the last three months and it has been outperformed by HIMS.
More positive than 63% of ticker scores this week
The company has shown robust top and bottom line improvement and stock outperformance, though offset by contracting gross margins.
More negative than 71% of ticker scores this week
Mentioned as a peer that has been outperformed by Hims & Hers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1d ago
More positive than 57% of relationship scores this week
[mutual] Hims & Hers is compared to Teladoc Health as a peer in the health and wellness platform space.
More positive than 57% of relationship scores this week
[mutual] Both companies are identified as peers in the same industry as Hims & Hers.
+135.8%
Price is moving against the score
$13.75 vs $5.83 close before publication (Oct 13) · not market-adjusted
AMWL chart →
